D-J in CLL | V-D-J in CLL | D-J in ALL | V-D-J in ALL | D-J versus V-D-J in CLL (P) | D-J versus V-D-J in ALL (P) | D-J in CLL versus ALL (P) | |
---|---|---|---|---|---|---|---|
TdT activity | |||||||
Positivity (%) | 96.9 | 92.0 | 90.0 | 89.8 | 0.03 | 0.92 | 0.01 |
Median number of nucleotides (range) | 9 (1–76) | 6 (1–81) | 0.01 | 0.96 | 0.13 | ||
3′ IGHD exonuclease activity Positivity (%) | 87.6 | 81.8 | 88.5 | 85.7 | 0.06 | 0.98 | 0.52 |
Median number of nucleotides (range) | 0.74 | 0.12 | 0.26 | ||||
5′ IGHJ exonuclease activity Positivity (%) | 86.6 | 86.6 | 85.4 | 77.6 | 0.99 | 0.08 | 0.84 |
Median number of nucleotides (range) | 0.39 | 0.06 | 0.06 |